MALT1: Difference between revisions
CSV import |
CSV import |
||
| Line 76: | Line 76: | ||
[[Category:Companies established in 1968]] | [[Category:Companies established in 1968]] | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 18:14, 17 March 2025
| MALT1 | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Lupin is a pharmaceutical company known for its production of generic medications and active pharmaceutical ingredients (APIs). It is one of the largest generic pharmaceutical companies in the world, with a significant presence in the United States, India, and Japan.
History[edit]
Lupin was founded in 1968 by Dr. Desh Bandhu Gupta in India. The company initially focused on producing vitamins and later expanded into the production of antibiotics and other pharmaceuticals. Over the years, Lupin has grown through strategic acquisitions and partnerships, establishing itself as a leader in the global pharmaceutical industry.
Products[edit]
Lupin manufactures a wide range of pharmaceutical products, including:
- Antibiotics
- Cardiovascular drugs
- Diabetes medications
- Central nervous system drugs
- Respiratory drugs
The company is particularly known for its expertise in the production of cephalosporins, a class of antibiotics.
Research and Development[edit]
Lupin invests heavily in research and development (R&D) to innovate and improve its product offerings. The company operates several R&D centers across the globe, focusing on the development of complex generics, biosimilars, and novel drug delivery systems.
Global Presence[edit]
Lupin has a strong international presence, with manufacturing facilities and offices in over 100 countries. The company has a significant market share in the United States, where it is one of the top suppliers of generic drugs.
Corporate Social Responsibility[edit]
Lupin is committed to corporate social responsibility (CSR) and engages in various initiatives to improve healthcare access and education in underserved communities. The Lupin Foundation, the company's CSR arm, focuses on rural development, healthcare, and education.
Controversies[edit]
Like many pharmaceutical companies, Lupin has faced legal and regulatory challenges. These include patent disputes and compliance issues with regulatory bodies such as the U.S. Food and Drug Administration (FDA).
Also see[edit]
| Pharmaceutical companies | ||||||
|---|---|---|---|---|---|---|
|
